Literature DB >> 2175396

Cloning and expression of a cDNA encoding an endothelin receptor.

H Arai1, S Hori, I Aramori, H Ohkubo, S Nakanishi.   

Abstract

Endothelins are a newly described peptide family consisting of three peptides (ET-1, ET-2 and ET-3) which are the most potent vasoconstrictive peptides known. They are crucial in the regulation of vascular smooth muscle tone. The diverse functions of endothelins are thought to be mediated by interaction with many different receptors coupled to the inositol phosphate/calcium ion messenger pathway. However, because of the structural resemblance of the three peptides, the presence and nature of multiple endothelin receptors remain to be elucidated. We report here the cloning of a complementary DNA encoding a bovine endothelin receptor, which has a transmembrane topology similar to that of other G protein-coupled receptors and shows specific binding, with the highest selectivity to ET-1 in animal cells transfected with the cloned cDNA. This receptor messenger RNA is widely distributed in the central nervous system and peripheral tissues, particularly in the heart and lung. Our results support the view that there are other receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175396     DOI: 10.1038/348730a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  416 in total

1.  ET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway.

Authors:  A M Evans; H J Cobban; G F Nixon
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Reversal of the vasoconstrictor step of hyperacute xenogeneic rejection of the liver by endothelin antagonists.

Authors:  B Zhang; L Wen; A Gomola; P P Massault; B Cherruau; D Houssin; B Weill; Y Calmus
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 3.  Structural basis of the function of endothelin receptor.

Authors:  T Masaki; H Ninomiya; A Sakamoto; Y Okamoto
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 4.  Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Isabella Sudano; Antonio Salvetti
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Potential role of endothelin receptor antagonists in the setting of cardiopulmonary bypass: relevance to myocardial performance.

Authors:  A Ergul; C Joffs; A C Walker; F G Spinale
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

6.  Evidence for two endothelin Et(A) receptor subtypes in rabbit arteriolar smooth muscle.

Authors:  T M Curtis; C N Scholfield
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

7.  Involvement of nuclear factor-kappaB in endothelin-A-receptor-induced proliferation and inhibition of apoptosis.

Authors:  M Mangelus; R Galron; Z Naor; M Sokolovsky
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

Review 8.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

9.  Endothelin receptor subtypes in human and guinea-pig pulmonary tissues.

Authors:  D W Hay; M A Luttmann; W C Hubbard; B J Undem
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

10.  Evidence for heterogeneity of endothelin receptor distribution in human coronary artery.

Authors:  T Godfraind
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.